Clinical Trials

121 enrolled 7 charts

Upper Gingival Squamous Cell Carcinoma

NCT07015333 2025-06-11

Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab

31 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT06322147 2024-03-20

Chemotherapy With Cetuximab as Conversion Therapy in RAS/BRAF WT Unresectable Liver Metastasis Right-sided Colon Cancer

50 enrolled

Colonic Neoplasms

NCT03914170 2023-09-26

ESTER

70 enrolled

Colorectal Neoplasms

NCT04359199 2023-02-10

QUASAR

42 enrolled

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT04673955 2022-09-29

BERING-CRC

Recruiting

500 enrolled

Colorectal Neoplasms

NCT04672772 2022-03-23

Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.

531 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03923036 2019-04-22

AVOCETTE

2,000 enrolled

Colorectal Cancer Metastatic

NCT01310985 2019-03-01

A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer

15 enrolled

Rectal Neoplasms

NCT03401957 2018-01-17

The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment

120 enrolled

Colorectal Neoplasms

NCT01134666 2017-06-09

An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer

Terminated

165 enrolled

Intestinal Neoplasms, Neoplasms, Colorectal Neoplasms

NCT01466257 2017-05-19

Biomarkers in Patients With Head and Neck Cancer

70 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01466244 2017-05-17

Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397

42 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01142869 2017-05-08

An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

Terminated

133 enrolled

Carcinoma, Squamous Cell, Neoplasms, Squamous Cell

NCT01382407 2017-04-27

Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab

100 enrolled

Acne Vulgaris

NCT02994888 2016-12-19

PROSPECT-C

47 enrolled

Colorectal Neoplasms

NCT01943786 2015-03-17

BEAMING

40 enrolled

Colorectal Cancer Metastatic

NCT01075828 2014-08-29

Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea

221 enrolled

Head and Neck Neoplasms, Neoplasms, Squamous Cell

NCT01082315 2014-08-29

A Korean Post-marketing Surveillance Study on Erbitux® in Patients With Metastatic Colorectal Cancer Refractory to Irinotecan-containing Treatment

730 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT01080066 2014-07-08

A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)

215 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma

NCT01075841 2014-07-02

A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck

Withdrawn

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms, Squamous Cell

NCT01074333 2014-06-17

An Observational Study of Erbitux® in Patients With Metastatic Colorectal Cancer (mCRC) Refractory to Irinotecan-containing Treatment

Terminated

146 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT00912327 2012-02-15

Efficacy and Safety Study of Imprime PGG With Cetuximab in Subjects With Stage IV KRAS-Mutated Colorectal Cancer

18 enrolled